Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bast

Showing results (401-410 of 560) with videos related to

Pageof 56
Sort By:
Gynecologic Oncology|December 31, 2002
Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancersJon R Wiener, T Christopher Windham, Veronica C Estrella, et al.
Autophagy|June 1, 2014
DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cellsZhen Lu, Maria T Baquero, Hailing Yang, et al.
Oncogene|February 19, 1998
Expression of p16 induces transcriptional downregulation of the RB geneX Fang, X Jin, H J Xu, et al.
Gynecologic Oncology|October 15, 2008
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massRichard G Moore, D Scott McMeekin, Amy K Brown, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 27, 2021
Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumorsAlexandra Blackman, Jessica Mitchell, Rachael Rowswell-Turner, et al.
Journal of the American Chemical Society|August 2, 2022
Structure-Based Design of Stapled Peptides That Bind GABARAP and Inhibit AutophagyHawley Brown, Mia Chung, Alina Üffing, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Blood|June 1, 1994
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow supportE J Shpall, S M Stemmer, L Hami, et al.
Cancer Research|December 25, 2002
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathwayJia-Ju Bao, Xiao-Feng Le, Rui-Yu Wang, et al.
Pageof 56

Showing results (401-410 of 560) with videos related to

Sort By:
Pageof 56
Gynecologic Oncology|December 31, 2002
Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancersJon R Wiener, T Christopher Windham, Veronica C Estrella, et al.
Autophagy|June 1, 2014
DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cellsZhen Lu, Maria T Baquero, Hailing Yang, et al.
Oncogene|February 19, 1998
Expression of p16 induces transcriptional downregulation of the RB geneX Fang, X Jin, H J Xu, et al.
Gynecologic Oncology|October 15, 2008
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massRichard G Moore, D Scott McMeekin, Amy K Brown, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|December 27, 2021
Analysis of serum HE4 levels in various histologic subtypes of epithelial ovarian cancer and other malignant tumorsAlexandra Blackman, Jessica Mitchell, Rachael Rowswell-Turner, et al.
Journal of the American Chemical Society|August 2, 2022
Structure-Based Design of Stapled Peptides That Bind GABARAP and Inhibit AutophagyHawley Brown, Mia Chung, Alina Üffing, et al.
Journal of the National Cancer Institute|December 12, 1992
Clonal origin of epithelial ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation, and X-chromosome inactivationI J Jacobs, M F Kohler, R W Wiseman, et al.
Gynecologic Oncology|February 1, 1994
Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumorsA Berchuck, M F Kohler, M P Hopkins, et al.
Blood|June 1, 1994
Amifostine (WR-2721) shortens the engraftment period of 4-hydroperoxycyclophosphamide-purged bone marrow in breast cancer patients receiving high-dose chemotherapy with autologous bone marrow supportE J Shpall, S M Stemmer, L Hami, et al.
Cancer Research|December 25, 2002
Reexpression of the tumor suppressor gene ARHI induces apoptosis in ovarian and breast cancer cells through a caspase-independent calpain-dependent pathwayJia-Ju Bao, Xiao-Feng Le, Rui-Yu Wang, et al.
Pageof 56